Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020

SELL
$4.9 - $7.12 $54,071 - $78,569
-11,035 Closed
0 $0
Q2 2020

Jun 26, 2023

BUY
$6.43 - $9.86 $70,955 - $108,805
11,035 New
11,035 $80,000
Q1 2020

Jul 12, 2023

BUY
$6.36 - $10.05 $70,182 - $110,901
11,035 New
11,035 $76,000
Q1 2020

Mar 30, 2023

BUY
$6.36 - $10.05 $8,834 - $13,959
1,389 Added 14.4%
11,035 $76,000
Q1 2020

May 15, 2020

BUY
$6.36 - $10.05 $8,834 - $13,959
1,389 Added 14.4%
11,035 $77,000
Q4 2019

Jul 12, 2023

BUY
$8.49 - $12.81 $81,894 - $123,565
9,646 New
9,646 $85,000
Q4 2019

Mar 30, 2023

SELL
$8.49 - $12.81 $13,303 - $20,073
-1,567 Reduced 13.97%
9,646 $85,000
Q4 2019

Feb 14, 2020

SELL
$8.49 - $12.81 $13,303 - $20,073
-1,567 Reduced 13.97%
9,646 $85,000
Q3 2019

Jul 12, 2023

BUY
$5.58 - $14.47 $62,568 - $162,252
11,213 New
11,213 $125,000
Q3 2019

Mar 30, 2023

BUY
$5.58 - $14.47 $7,393 - $19,172
1,325 Added 13.4%
11,213 $125,000
Q3 2019

Nov 14, 2019

BUY
$5.58 - $14.47 $62,568 - $162,252
11,213 New
11,213 $126,000
Q2 2019

Jul 12, 2023

BUY
$5.22 - $9.08 $51,615 - $89,783
9,888 New
9,888 $59.9 Million
Q2 2019

Aug 14, 2019

SELL
$5.22 - $9.08 $51,615 - $89,783
-9,888 Closed
0 $0
Q1 2019

Jul 13, 2023

BUY
$5.35 - $9.82 $52,900 - $97,100
9,888 New
9,888 $77,000
Q1 2019

Mar 30, 2023

BUY
$5.35 - $9.82 $52,900 - $97,100
9,888 New
9,888 $77,000
Q1 2019

May 16, 2019

SELL
$5.35 - $9.82 $101,061 - $185,499
-18,890 Reduced 65.64%
9,888 $77,000
Q1 2019

May 15, 2019

BUY
$5.35 - $9.82 $153,962 - $282,599
28,778 New
28,778 $1.17 Million
Q3 2018

Nov 14, 2018

SELL
$4.75 - $14.5 $47,443 - $144,826
-9,988 Closed
0 $0
Q4 2017

Feb 15, 2018

SELL
$19.9 - $29.25 $181,726 - $267,111
-9,132 Reduced 47.76%
9,988 $232,000
Q2 2017

Aug 14, 2017

BUY
N/A
19,120
19,120 $390,000

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.